Literature DB >> 9139974

Modulation of SERCA2 expression by thyroid hormone and norepinephrine in cardiocytes: role of contractility.

A Muller1, M J Zuidwijk, W S Simonides, C van Hardeveld.   

Abstract

Decreased expression of the cardiac slow-twitch sarcoplasmic reticulum Ca2+-adenosinetriphosphatase (SERCA2), a major determinant of Ca2+ homeostasis, contributes to the abnormal intracellular Ca2+ handling in the failing heart. We investigated the contractility dependence of the effects of norepinephrine (NE) and thyroid hormone (T3) on SERCA2 expression in cultured neonatal heart cells under serum-free conditions. NE and T3 are associated with pathological and physiological forms of hypertrophy, respectively, whereas both hormones increase contractility. In contracting cultures, T3 increased SERCA2 protein and mRNA levels by 35 and 110%, respectively. The same stimulatory effects of T3 on SERCA2 expression were found in contraction-arrested cells. In contracting cultures, NE induced a decrease of SERCA2 protein and mRNA levels by 40 and 60%, respectively. In contrast, SERCA2 protein and mRNA levels were not decreased by NE in contraction-arrested cells, indicating that contractility is a prerequisite for the negative influence of NE on SERCA2 expression. Electrical stimulation at a fixed frequency in the presence and absence of NE demonstrated that the NE-induced increase in contraction frequency is unlikely to account for the decreased SERCA2 expression induced by NE. The results suggest that the effect of contractility on SERCA2 expression depends on the signal transduction pathways that are activated by NE and T3.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9139974     DOI: 10.1152/ajpheart.1997.272.4.H1876

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  M-protein is down-regulated in cardiac hypertrophy driven by thyroid hormone in rats.

Authors:  Andrei Rozanski; Ana Paula C Takano; Patricia N Kato; Antonio G Soares; Camilo Lellis-Santos; Juliane Cruz Campos; Julio Cesar Batista Ferreira; Maria Luiza M Barreto-Chaves; Anselmo S Moriscot
Journal:  Mol Endocrinol       Date:  2013-10-31

2.  Endothelin-1 prolongs intracellular calcium transient decay in neonatal rat cardiac myocytes.

Authors:  Yoshiki Uehara; Yoshiyuki Azuma; Kosuke Minai; Hiroshi Yoshida; Michihiro Yoshimura; Mitsuyuki Shimizu
Journal:  Heart Vessels       Date:  2011-03-29       Impact factor: 2.037

3.  Triiodothyronine promotes cardiac differentiation and maturation of embryonic stem cells via the classical genomic pathway.

Authors:  Yee-Ki Lee; Kwong-Man Ng; Yau-Chi Chan; Wing-Hon Lai; Ka-Wing Au; Chung-Yee Jenny Ho; Lai-Yung Wong; Chu-Pak Lau; Hung-Fat Tse; Chung-Wah Siu
Journal:  Mol Endocrinol       Date:  2010-07-28

4.  Mice with cardiomyocyte-specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy.

Authors:  Ralph V Shohet; Yaz Y Kisanuki; Xiao-Song Zhao; Zakir Siddiquee; Fatima Franco; Masashi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-05       Impact factor: 11.205

5.  Endothelin downregulates SERCA2 gene and protein expression in adult rat ventricular myocytes: regulation by pertussis toxin-sensitive Gi protein and cAMP.

Authors:  Randa Hilal-Dandan; Huaping He; Jody L Martin; Laurence L Brunton; Wolfgang H Dillmann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-16       Impact factor: 4.733

6.  American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models.

Authors:  Antonio C Bianco; Grant Anderson; Douglas Forrest; Valerie Anne Galton; Balázs Gereben; Brian W Kim; Peter A Kopp; Xiao Hui Liao; Maria Jesus Obregon; Robin P Peeters; Samuel Refetoff; David S Sharlin; Warner S Simonides; Roy E Weiss; Graham R Williams
Journal:  Thyroid       Date:  2013-12-12       Impact factor: 6.568

7.  Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent: In vivo and in vitro data.

Authors:  Sabine Fredersdorf; Christian Thumann; Wolfram H Zimmermann; Roland Vetter; Tobias Graf; Andreas Luchner; Günter Aj Riegger; Heribert Schunkert; Thomas Eschenhagen; Joachim Weil
Journal:  Cardiovasc Diabetol       Date:  2012-05-23       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.